H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

Background. We investigated antibody persistence in children 1 year after 2 doses of either an AS03(B)-adjuvanted split-virion or nonadjuvanted whole-virion monovalent pandemic influenza vaccine and assessed the immunogenicity and reactogenicity of a subsequent dose of trivalent influenza vaccine (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Woolf T., de Whalley, Philip, Andrews, Nick, Oeser, Clarissa, Casey, Michelle, Michaelis, Louise, Hoschler, Katja, Harrill, Caroline, Moulsdale, Phoebe, Thompson, Ben, Jones, Claire, Chalk, Jem, Kerridge, Simon, John, Tessa M., Okike, Ifeanyichukwu, Ladhani, Shamez, Tomlinson, Richard, Heath, Paul T., Miller, Elizabeth, Faust, Saul N., Snape, Matthew D., Finn, Adam, Pollard, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275760/
https://www.ncbi.nlm.nih.gov/pubmed/22267719
http://dx.doi.org/10.1093/cid/cir905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275760/
https://www.ncbi.nlm.nih.gov/pubmed/22267719
http://dx.doi.org/10.1093/cid/cir905

Ejemplares similares